Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control

Kate Connolly1, Pete Manders, Peter Earls

  • 1Department of Oncology, St. Vincent's Hospital, The Kinghorn Cancer Centre, UNSW Clinical School, Sydney, Australia.

Cancer Treatment Reviews
|September 21, 2013
PubMed

Insights

Transplant patients frequently develop skin squamous cell carcinomas (SCCs) with human papillomaviruses (HPVs). Immunosuppression, UV damage, and HPV signaling interplay to drive SCC development, necessitating strategy reappraisal.

Area of Science:

  • Dermatology
  • Oncology
  • Virology

Background:

  • Cutaneous squamous cell carcinomas (SCCs) are common in organ transplant recipients, often associated with human papillomaviruses (HPVs).
  • The precise mechanisms linking immunosuppression, HPV, and SCC development remain incompletely understood.
  • Recent findings illuminate the roles of specific HPV types, genetic syndromes, and therapeutic interventions in SCC pathogenesis.

Purpose of the Study:

  • To elucidate the complex interplay between iatrogenic immunosuppression, human papillomaviruses (HPVs), and the development of cutaneous squamous cell carcinomas (SCCs).
  • To integrate recent insights into HPV associations, immunosuppressive drug effects, and tumor microenvironment signaling in SCC pathogenesis.
  • To inform reappraisal of management strategies for skin SCCs in transplant patients.

Main Methods:

  • Review and synthesis of recent findings on HPV-beta (β) and HPV-alpha (α) types in SCCs.
  • Analysis of the impact of immunosuppressive agents (calcineurin inhibitors, mTOR inhibitors) on tumor control.
  • Investigation of the role of UV radiation, TP53 mutations, and Notch signaling in SCC development.

Main Results:

  • Low-risk β-HPVs are associated with SCCs in genetic syndromes; high-risk α-HPVs in oropharyngeal SCCs have a favorable prognosis.
  • Substitution of calcineurin inhibitors with mTOR inhibitors often improves post-transplant tumor control.
  • β-HPV E6 oncoproteins inhibit Notch signaling, potentially exacerbating SCC development in conjunction with UV damage and immunosuppression.

Conclusions:

  • A complex interplay exists between UV-induced mutations, impaired immunity, and β-HPV-driven signaling in skin SCCs.
  • Calcineurin inhibitors may intensify mitogenic signaling in TP53-mutant keratinocytes and reduce immune-mediated tumor repression.
  • Reappraising management strategies for skin SCCs in transplant patients is timely given these insights.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...